MeMed Diagnostics is developing solutions for the diagnosis of infectious disease and inflammatory disorders. MeMed's ImmunoXpert is a novel assay that accurately distinguishes between bacterial and viral infections based on the patient immune response to different infection types. ImmunoXpert provides physicians with rapid and actionable clinical information to help guide antibiotic treatment decisions.
|HQ||Tirat Carmel, IL||Map|
|Employees (est.) (Apr 2021)||85||(+4%)|
MeMed total Funding
MeMed latest funding size
Time since last funding
|2 years ago|
|Horizons Ventures, WTI, OurCrowd, Phoenix Insurance, Social Capital, Spectrum 28, Foxconn, EASME - EU Executive Agency for SMEs, Clal Insurance, Ping An Global Voyager Fund, Caesarea Medical Holdings, European Innovation Council, Congressionally Directed Medical Research Programs|
MeMed has 317 Twitter Followers. The number of followers has increased 0.3% month over month and increased 0.6% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was MeMed founded?
MeMed was founded in 2009.
How many employees does MeMed have?
MeMed has 85 employees.
Who are MeMed competitors?
Competitors of MeMed include Appello Pharmaceuticals, ImevaX and Cassava Sciences.
Where is MeMed headquarters?
MeMed headquarters is located at Nahum Het St 5, Tirat Carmel.
Where are MeMed offices?
MeMed has an office in Tirat Carmel.
How many offices does MeMed have?
MeMed has 1 office.
Receive alerts for 300+ data fields across thousands of companies